Althea Group (Australia) Today
| AGH Stock | 0.03 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 86
|
Althea Group is selling for under 0.034 as of the 31st of January 2025; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 0.034. Althea Group has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 2nd of November 2024 and ending today, the 31st of January 2025. Click here to learn more.
Moving against Althea Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Althea Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Althea Group's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Althea Group or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| MD CEO | Joshua Fegan |
| Business Concentration | Health Care, Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Althea Group Holdings (AGH) is traded on Australian Securities Exchange in Australia and employs 4 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Althea Group's market, we take the total number of its shares issued and multiply it by Althea Group's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Althea Group Holdings operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 406.5 M outstanding shares.
Althea Group generates negative cash flow from operations
Check Althea Group Probability Of Bankruptcy
Ownership AllocationAlthea Group holds a total of 406.5 Million outstanding shares. Althea Group Holdings retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Althea Ownership Details
Althea Group Holdings Risk Profiles
Although Althea Group's alpha and beta are two of the key measurements used to evaluate Althea Group's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.23 | |||
| Standard Deviation | 2.14 | |||
| Variance | 4.59 | |||
| Risk Adjusted Performance | (0.15) |
Althea Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Althea Group without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Althea Group Corporate Executives
Elected by the shareholders, the Althea Group's board of directors comprises two types of representatives: Althea Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Althea. The board's role is to monitor Althea Group's management team and ensure that shareholders' interests are well served. Althea Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Althea Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert Meissner | CFO Secretary | Profile |
Additional Tools for Althea Stock Analysis
When running Althea Group's price analysis, check to measure Althea Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Althea Group is operating at the current time. Most of Althea Group's value examination focuses on studying past and present price action to predict the probability of Althea Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Althea Group's price. Additionally, you may evaluate how the addition of Althea Group to your portfolios can decrease your overall portfolio volatility.